Gap junction-mediated bystander effect in primary cultures of human malignant gliomas with recombinant expression of the HSVtk gene

Exp Cell Res. 2003 Apr 1;284(2):185-95. doi: 10.1016/s0014-4827(02)00052-6.

Abstract

The ability of herpes simplex virus type 1 thymidine kinase (HSV-tk)-expressing cells incubated with ganciclovir (GCV) to induce cytotoxicity in neighboring HSV-tk-negative (bystander) cells has been well documented. Although it has been suggested that this bystander cell killing occurs via the transfer of phosphorylated GCV, the mechanism(s) of this bystander effect and the importance of gap junctions for the effect of prodrug/suicide gene therapy in primary human glioblastoma cells remains elusive. Surgical biopsies of malignant gliomas were used to establish explant primary cultures. Proliferating tumor cells were characterized immunohistochemically and found to express glial tumor markers including nestin, vimentin, glial fibrillary acidic protein (GFAP), S-100, and gap junction protein connexin 43 (Cx43). Western blot analysis revealed the presence of phosphorylated isoforms of Cx43 and Calcein/DiI fluorescent dye transfer showed evidence of efficient gap junction communication (GJC). In order to study the effect(s) of prodrug/suicide gene therapy in these cultures, human glioblastoma cell cultures were transfected with the HSVtk gene for transient or stable expression. Ganciclovir treatment of these cultures led to >90% of cells dead within 1 week. Eradication of cells could be inhibited by the addition of alpha-glycyrrhetinic acid (AGA), a GJC inhibitor. In parallel experiments, AGA decreased the immunodetection of phosphorylated Cx43 as analyzed by Western blot and inhibited fluorescent dye transfer. In conclusion, these observations are consistent with GJC as the mediator of the bystander effect in primary cultures of human glioblastoma cells by the transfer of phosphorylated GCV from HSVtk gene transfected cells to untransfected ones.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Biomarkers, Tumor
  • Brain Neoplasms / drug therapy*
  • Brain Neoplasms / genetics
  • Brain Neoplasms / metabolism
  • Cell Communication / drug effects*
  • Cell Communication / genetics
  • Cell Death / drug effects
  • Cell Death / genetics
  • Connexin 43 / metabolism
  • Cytotoxins / genetics
  • Cytotoxins / pharmacology*
  • Cytotoxins / therapeutic use
  • Ganciclovir / pharmacology*
  • Ganciclovir / therapeutic use
  • Gap Junctions / drug effects*
  • Gap Junctions / genetics
  • Gap Junctions / metabolism
  • Glioma / drug therapy*
  • Glioma / genetics
  • Glioma / metabolism
  • Glycyrrhetinic Acid / pharmacology
  • Glycyrrhetinic Acid / therapeutic use
  • Humans
  • Phosphorylation / drug effects
  • Thymidine Kinase / genetics
  • Thymidine Kinase / pharmacology*
  • Thymidine Kinase / therapeutic use
  • Tumor Cells, Cultured
  • Viral Proteins / genetics
  • Viral Proteins / pharmacology*
  • Viral Proteins / therapeutic use

Substances

  • Biomarkers, Tumor
  • Connexin 43
  • Cytotoxins
  • Viral Proteins
  • thymidine kinase, Canid herpesvirus 1
  • Thymidine Kinase
  • Glycyrrhetinic Acid
  • Ganciclovir